Rothman Orthopaedics Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02476903
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Rothman Orthopaedic | Rothman Orthopaedics | Sean McMillan, DO

Active Ingredients

Drugs in Phase 4 Trials (2)

ketorolac (acuvail) (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (1)

hyaluronic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ankle Fractures (Phase 4)

Rotator Cuff Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3